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ABSTRACT
At birth, the neonatal skeleton contains 20 to 30 g calcium (Ca). It is hypothesized maternal bone mineral may be mobilized to sup-
port fetal skeletal development, although evidence of pregnancy-inducedmineral mobilization is limited. We recruited healthy preg-
nant (n = 53) and non-pregnant non-lactating (NPNL; n = 37) women aged 30 to 45 years (mean age 35.4  3.8 years) and obtained
peripheral quantitative computed tomography (pQCT) and high-resolution pQCT (HR-pQCT) scans from the tibia and radius at 14 to
16 and 34 to 36 weeks of pregnancy, with a similar scan interval for NPNL. Multiple linear regression models were used to assess
group differences in change between baseline and follow-up; differences are expressed as standard deviation scores (SDS)  SEM.
Decreases in volumetric bone mineral density (vBMD) outcomes were found in both groups; however, pregnancy-related decreases
for pQCT total and trabecular vBMDwere−0.65  0.22 SDS and−0.50  0.23 SDS greater (p < .05). HR-pQCT total and cortical vBMD
decreased compared with NPNL by−0.49  0.24 SDS and−0.67  0.23 SDS, respectively; trabecular vBMD decreased in both groups
to a similar magnitude. Pregnancy-related changes in bone microarchitecture significantly exceeded NPNL change for trabecular
number (0.47  0.23 SDS), trabecular separation (−0.54  0.24 SDS), cortical thickness (−1.01  0.21 SDS), and cortical perimeter
(0.78  0.23 SDS). At the proximal radius, cortical vBMD and endosteal circumference increased by 0.50  0.23 SDS and
0.46  0.23 SDS, respectively, compared with NPNL, whereas cortical thickness decreased −0.50  0.22 SDS. Pregnancy-related
decreases in total and compartment-specific vBMD exceed age-related change at the distal tibia. Changes at the radius were only
evident with pQCT at the cortical-rich proximal site and suggest endosteal resorption. Although the magnitude of these
pregnancy-related changes in the appendicular skeleton are small, if they reflect global changes across the skeleton at large, they
may contribute substantially to the Ca requirements of the fetus. © 2020 Crown copyright. Journal of Bone and Mineral Research pub-
lished by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). This article is published with
the permission of the Controller of HMSO and the Queen’s Printer for Scotland.
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Introduction
Reproduction places increased pressure on maternal mineraleconomy to supply essential nutrients during pregnancy.
Fetal calcium (Ca) accretion increases from approximately
50 mg/d at 20 weeks to 330 mg/d at 35 weeks,(1) and at birth
a newborn skeleton contains 20 to 30 g Ca.(2) Biological strate-
gies allow the mother to meet these extra nutritional demands.
These may include increases in mineral intake and physiological
adaptations including increased gastrointestinal absorption,
increased renal clearance, increased urinary excretion, and
potentially bone mineral mobilization.(3–7) Several studies have
tried to quantify pregnancy-induced bone loss but with conflict-
ing results.(7–20) From the available data, pregnancy and
lactation are not considered risk factors for osteoporosis,(6)
although as noted in a recent review, there may be permanent
alterations in skeletal structure with implications for the meta-
bolic and mechanical function of bone.(21)
A broad variety of techniques including circulating hormone
levels,(22–27) bone turnover markers (BTM),(15,28–31) bone histo-
morphology via bone biopsies,(32,33) quantitative ultrasound
(QUS),(34,35) and circulating lead concentrations(36) have been
used. However, the few studies that have used X-ray-based
techniques to explore pregnancy-related skeletal changes have
typically either obtained dual-energy X-ray absorptiometry
(DXA) scans pre-pregnancy and postpartum or scanned the
forearm with DXA during pregnancy to quantify the changes in
areal bone mineral density (aBMD). Both these approaches have
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limitations because comparing pre-pregnancy and postpartum
scans are confounded by the initiation of lactation, and forearm
DXA cannot distinguish between cortical and trabecular bone.
Peripheral quantitative computed tomography (pQCT) and high
resolution (HR)-pQCT overcome these limitations and involve a
minimal amount of ionizing radiation. Despite this, to date, only
two studies in pregnancy have been published using single-slice
pQCT(37,38) and none using HR-pQCT.
Therefore, this study aimed to quantify the extent of pregnancy-
induced changes in compartmental (trabecular and cortical) volu-
metric BMD (vBMD) and bone mineral microarchitecture using
pQCT and HR-pQCT techniques between the early second (14 to
16 weeks) and the third trimester (34 to 36 weeks) in UK women
aged 30 to 45 years. This age range was selected to focus on the
groups where numbers of pregnancies have risen most rapidly in
recent years.(39) As age-related changes in pQCT and HR-pQCT
bone outcome measures have been reported in non-pregnant
non-lactating (NPNL) women in this age range,(40–42) a control
group of healthy NPNLwomenwas followedover the sameperiod.
The primary hypothesis was that in pregnant women, there would
be decreases in trabecular vBMDmeasured by pQCT and HR-pQCT
and changes in trabecular microarchitecture as measured by HR-
pQCT (ie, reduced trabecular thickness and reduced trabecular
number). Secondary hypotheses were that there would be
reduced cortical thickness and density in addition to endosteal
resorption at the proximal radius and tibia by pQCT and distal
radius and tibia by HRpQCT.
Materials and Methods
Recruitment
Women with a singleton pregnancy achieved by natural concep-
tion and aged 30 to 45 years were recruited between March
2017 andDecember 2018 at the Rosie Hospital CambridgeUniver-
sity Hospitals (CUH), Cambridge, UK. Pregnant women were
approached at their 12-week dating ultrasound scan by research
midwives not actively involved in the participants’ care. Pregnant
women were also recruited from the local community through
advertisements but only if they were under the medical care of
the Rosie Hospital. Participants received a participant information
sheet and were subsequently screened by a member of the
research team via telephone interview. Visit 1 took place between
14 and 16 weeks of gestation, based on estimated gestational age
from the 12-week dating scan. A control group of healthy NPNL
women in the same age range was recruited from the local com-
munity through posters and online advertisements and screened
by telephone interview. Eligibility criteria for both groups were
age 30 to 45 years, at least 3 months since cessation of lactation
from previous pregnancy, no history of prolonged periods of
amenorrhea, not taking medications known to alter bone or Ca
metabolism, no history of conditions affecting bone or Ca metab-
olism, no history of prolonged immobilization or bed rest and the
ability to give informed written consent. Before follow-up, the
continuing eligibility of pregnant participants was reassessed at
30 weeks’ gestation by the midwives by telephone. Participants
who had serious pregnancy complications or who had moved
from the area were not invited to attend the follow-up visit.
Ethical approval was obtained from the East of England–Essex
Research Ethics Committee (REC) (Project ID 199857) and R&D
approval was obtained from Cambridge University Hospitals
(reference number A094123). Informed written consent for all
participants was acquired at the baseline visit.
Anthropometry
Anthropometric measurements were made at each visit. Height
(cm) was obtained without footwear to the nearest 1 mmusing a
wall-mounted stadiometer (Seca GmbH, Hamburg, Germany).
Weight (kg) was measured using a digital scale to the nearest
0.1 kg, while the participants wore light clothing without foot-
wear (Seca GmbH, Hamburg, Germany). Subsequently body
mass index (BMI, kg/m2) was calculated. To determine the appro-
priate scan sites for pQCT, both forearm and lower-leg length
were measured to the nearest 1 mm using a metal rule: Tibia
length was measured from the distal edge of the medial malleo-
lus to the tibial plateau; ulna length was recorded as the distance
from the olecranon to the ulnar styloid process.
Bone densitometry
Peripheral QCT (XCT 2000L, Stratec Medizintechnik, Pforzheim,
Germany) and HR-pQCT (Scanco XtremeCTI, Scanco Medical
AG, Bruttisellen, Switzerland) scans at both baseline and follow-
up were acquired at the nondominant radius and tibia unless
there had been a previous fracture or injury necessitating the
immobilization of the limb, when the dominant limb was
scanned. The total effective dose to the participant was esti-
mated to be <18.4 μSv.
pQCT
pQCT scans were obtained, with a voxel size of 0.5 × 0.5 mm and
slice thickness of 2 mm, at the radius (at 4% and 33% of the limb
length proximal to the distal endplate) and tibia (at 4% and 38%
of the limb length proximal to the distal endplate). CT scan speed
was 30 mm/s and scout view scan speed was 40 mm/s. pQCT
scans were processed using the manufacturer’s software
(Stratec XCT version 6.2). At distal 4% sites, CALCBD analysis
was used to calculate total cross-sectional area (CSA) and total
and trabecular vBMD. CALCBD contour mode 1 (ie, threshold
algorithm) was used to exclude pixels in the defined region
of interest (ROI) that fell below the default threshold of
180 mg/cm3; peel mode 1 (ie, concentric peel) peeled away the
outer 55% of the total CSA of the bone, leaving an inner 45%
CSA considered to be purely trabecular. At proximal cortical-rich
sites, CORTBD was used to define cortical vBMD and area. The
algorithm removes all voxels within the ROI that have an attenu-
ation coefficient below the threshold. The default threshold






Age (years) 35.0 (3.7) 36.0 (4.0)
Weight at visit 1 (kg) 68.2 (13.6) 70.4 (13.7)
Height (cm) 165.3 (5.9) 164.2 (7.2)
BMI (m/kg2) 24.9 (4.5) 26.2 (5.2)
Parity, median [IQR] 1 [0, 2] 2 [0, 4]1
Contraceptive use (ever), n (%) 43 (93) 34 (92)
Smoking (ever), n (%) 18 (39) 13 (35)
Weeks pregnant at visit 1 15.2 (2) —
Weeks pregnant at visit 2 35.4 (2.2) —
Weeks between visits 20.1 (2.0) 21.7 (1.7)
BMI = body mass index.
1 p < .05 Mann–Whitney U test between groups at baseline.
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of 710 mg/cm3 was used with separation mode 1. Total CSA was
defined at proximal sites at a threshold of 280 mg/cm3. Cortical
thickness, endosteal circumference, and periosteal circumfer-
ence were calculated using a circular ring model. Scans were
qualitatively graded by visual inspection to assess their suitability
for longitudinal analysis: Scan slices with excessive movement or
other artifacts and scout views that did not match longitudinally
were excluded. Calibration of the XCT 2000 L system was per-
formed on a routine basis with the manufacturer’s phantom:
Daily QA scans andweekly QC scans were performed throughout
the study period to test scanner performance. At our research
site, the precision for pQCT has been calculated to be 0.4% to
1.6% at the tibia and 0.9% to 4.3% at the radius by performing
two repeat scans on 30 participants.
High-resolution pQCT
HR-pQCT scans were obtained with the manufacturer’s
guidelines as described by Boutroy and colleagues.(43)
Briefly, before the initiation of each scan, antero-posterior
2D scout views were performed to determine the scan
region with a reference line manually placed at the endplate
of the radius or tibia. After this, a stack of parallel CT slices
was acquired using a 2D detector array; the first slice was
obtained 9.5 mm and 22.5 mm proximal to the reference
line for the radius and tibia, respectively. All scans were
acquired by trained technicians using the standard position-
ing techniques.(43) The quality of the HR-pQCT scans of the
distal radius and tibia was assessed using a five-grade
Table 2.Descriptive Statistics at Visits 1 and 2 andMean Difference Between Visits Expressed as Percentages (Mean  SD) for pQCT- and
HR-pQCT-Measured Bone Density, Microarchitecture, and Geometry Parameters at the Tibia in Pregnant and Non-Pregnant
Non-Lactating Women (NPNL)
Pregnant NPNL
Visit 1 Visit 2 Δ% Visit 1 Visit 2 Δ%
HR-pQCT distal tibia n = 33 n = 32
Total vBMD (mg/cm3) 317.43 (68.09) 312.73 (66.02) −1.39 (1.73)3 315.26 (53.64) 313.77 (53.70) −0.48 (1.00)2
Cortical vBMD
(mg/cm3)
916.26 (38.81) 908.84 (39.13) −0.81 (1.37)2 921.45 (33.66) 920.60 (33.21) −0.08 (0.70)
Trabecular vBMD
(mg/cm3)
174.68 (41.33) 171.90 (40.26) −1.48 (1.97)3 165.53 (38.02) 162.98 (37.70) −1.56 (1.48)3
Trabecular number
(mm−1)
1.98 (0.27) 2.07 (0.30) 4.58 (7.61)2 2.13 (0.27) 2.12 (0.31) −0.29 (7.18)
Trabecular thickness
(mm)
0.07 (0.01) 0.07 (0.01) −5.35 (6.68)3 0.07 (0.01) 0.06 (0.01) −0.78 (6.92)
Trabecular
separation (mm)
0.44 (0.08) 0.43 (0.08) −3.66 (6.75)3 0.41 (0.06) 0.42 (0.07) 1.10 (7.43)
Cortical thickness
(mm)
1.21 (0.29) 1.20 (0.28) −1.21 (1.75)2 1.25 (0.22) 1.26 (0.22) 0.78 (1.06)3
Cortical perimeter
(mm)
99.6 (8.3) 99.80 (8.31) 0.25 (0.25)3 99.91 (7.16) 99.93 (7.15) 0.03 (0.24)
pQCT 4% tibia n = 43 n = 34
Total vBMD (mg/cm3) 306.25 (47.42) 303.18 (46.14) −0.95 (1.56)3 301.57 (40.36) 301.39 (40.77) −0.07 (1.04)
Trabecular vBMD
(mg/cm3)
227.91 (44.01) 225.75 (44.15) −0.98 (1.65)3 219.59 (39.15) 218.70 (39.14) −0.42 (1.08)1
Total CSA (mm2) 980.36 (115.47) 975.63 (112.06) −0.44 (1.40)1 989.76 (111.06) 989.08 (108.15) −0.03 (1.09)
pQCT 38% tibia n = 42 n = 35
Total CSA (mm2) 378.45 (43.34) 379.37 (43.93) 0.24 (1.02) 392.90 (45.52) 394.16 (45.56) 0.32 (1.08)
Cortical vBMD
(mg/cm3)
1172.08 (19.34) 1170.56 (18.77) −0.13 (0.51) 1169.09 (24.25) 1169.23 (23.04) 0.02 (0.40)
Cortical BMC
(mg/mm)
315.44 (38.98) 315.18 (39.11) −0.07 (1.35) 324.76 (40.87) 324.59 (40.97) −0.05 (1.03)
Cortical CSA (mm2) 269.21 (33.59) 269.36 (33.98) 0.06 (1.39) 277.81 (34.70) 277.60 (34.54) −0.07 (1.26)
Cortical thickness
(mm)








40.34 (3.52) 40.72 (3.52) 0.97 (2.19)2 41.24 (5.20) 41.70 (5.25) 1.14 (2.06)2
Bold indicates a statistically significant finding i.e. (p < .05).
vBMD = volumetric bone mineral density; CSA = cross-sectional area.
1 p < .05.
2 p < .01.
3 p < .001 single-sided t test versus 0.
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scale.(44) Images with significant motion artifacts causing
blurring and discontinuities in the cortical shell were
excluded. HR-pQCT scans were selected for longitudinal
analysis if the matched-common region between baseline
and follow-up scans was ≥80%. The matching of scans used
the standard methodology from Scanco.(43) All HR-pQCT out-
come measures were obtained using the manufacturer’s
standard evaluation.(43) In contrast to conventional pQCT,
trabecular vBMD was derived by system-defined boundaries
based on thresholding without manual correction. Coeffi-
cients of variation for HR-pQCT from the manufacturer’s
standard analysis have been reported as 0.1% to 0.3% and
1.1% to 4.8% for density parameters and 0.4% to 5.2% and
2.7% to 12.7% bone microarchitecture at the tibia and radius,
respectively.(45)
Fracture history and lifestyle questionnaire
Additional information relevant to bone health, including parity,




In the absence of published values of pregnancy-related
changes using pQCT or HR-pQCT, DXA-measured size-adjusted
bone mineral content (BMC) at the lumber spine between pre-
pregnancy and 2 weeks postpartum of 2.6%  4.2 SEM(7) was
used for the sample size calculation. This determined that a
sample size of 35 participants would be required to detect
within-group change in BMD from the first set of measurements
(baseline, early second trimester of pregnancy) to the second
measurements (third trimester of pregnancy) with a power of
0.9 and significance of 0.05. An equal number of NPNLparticipants
would be recruited to determine natural-age related changes.
Data analysis
All analyses were performed using R version 3.3.2 (R Foundation
for Statistical Computing, Vienna, Austria; https://www.r-project.
org/) with dplyr (version 0.8.3) for data manipulation.(46) Baseline
descriptive data are presented as mean (SD), except for parity,
expressed as median (IQR), and for the number of participants
Table 3.Descriptive Statistics at Visits 1 and 2 andMean Difference Between Visits Expressed as Percentages (Mean  SD) for pQCT- and
HR-pQCT-Measured Bone Density, Microarchitecture, and Geometry Parameters at the Radius in Pregnant and Non-Pregnant
Non-Lactating Women (NPNL)
Pregnant NPNL
Visit 1 Visit 2 Δ% Visit 1 Visit 2 Δ%
HR-pQCT distal radius n = 33 n = 27
Total vBMD (mg/cm3) 334.20 (58.74) 331.32 (60.12) −0.94 (2.04)1 334.75 (63.13) 331.61 (62.23) −0.90 (2.31)1
Cortical vBMD (mg/cm3) 920.46 (42.47) 916.15 (43.84) −0.47 (1.05)1 916.35 (49.22) 912.91 (49.78) −0.37 (1.12)
Trabecular vBMD
(mg/cm3)
153.28 (39.86) 151.11 (40.09) −1.54 (2.07)3 155.10 (32.80) 152.57 (33.02) −1.74 (1.49)3
Trabecular number
(mm−1)
1.95 (0.34) 1.96 (0.33) 1.27 (10.99) 2.02 (0.23) 2.06 (0.27) 2.06 (10.11)
Trabecular thickness
(mm)
0.07 (0.01) 0.06 (0.01) −1.79 (9.76) 0.06 (0.01) 0.06 (0.012) −2.93 (8.58)1
Trabecular separation
(mm)
0.46 (0.10) 0.46 (0.10) −0.012 (9.93) 0.44 (0.06) 0.43 (0.069) −0.86 (9.61)
Cortical thickness (mm) 0.82 (0.14) 0.82 (0.15) −0.75 (3.40) 0.81 (0.16) 0.81 (0.15) 0.50 (3.98)
Cortical perimeter (mm) 66.68 (5.80) 66.75 (6.00) 0.07 (0.52) 66.74 (5.35) 66.65 (5.35) −0.16 (0.56)
pQCT 4% radius n = 40 n = 31
Total vBMD (mg/cm3) 314.64 (48.69) 313.37 (45.96) −0.12 (5.33) 323.20 (51.77) 326.05 (52.52) 0.96 (4.46)
Trabecular vBMD
(mg/cm3)
176.45 (32.83) 176.51 (32.36) 0.16 (3.04) 180.41 (38.03) 181.17 (37.44) 0.52 (2.38)
Total CSA (mm2) 335.80 (45.41) 336.14 (45.95) 0.18 (4.31) 328.69 (45.69) 328.25 (46.64) −0.09 (4.06)
pQCT 33% radius n = 41 n = 35
Total CSA (mm2) 98.05 (12.56) 98.13 (12.54) 0.10 (1.30) 99.43 (12.33) 98.92 (11.95) −0.46 (1.54)
Cortical vBMD (mg/cm3) 1217.49 (15.81) 1220.46 (13.32) 0.25 (1.02) 1218.13 (17.45) 1216.82 (17.34) −0.11 (0.64)
Cortical BMC (mg/mm) 87.66 (10.31) 88.06 (10.37) 0.47 (1.18)1 88.88 (9.37) 89.08 (9.41) 0.22 (1.11)
Cortical CSA (mm2) 72.02 (8.55) 72.17 (8.59) 0.23 (1.65) 72.96 (7.63) 73.21 (7.72) 0.33 (1.41)
Cortical thickness (mm) 2.55 (0.22) 2.56 (0.22) 0.43 (2.79) 2.54 (0.21) 2.58 (0.22) 1.63 (2.96)2
Periosteal circumference
(mm)
36.21 (2.34) 36.19 (2.32) −0.04 (1.50) 36.68 (2.08) 36.46 (2.06) −0.61 (1.49)1
Endosteal circumference
(mm)
20.20 (2.30) 20.08 (2.29) −0.34 (4.35) 20.71 (2.10) 20.22 (2.12) −2.26 (4.62)2
Bold indicates a statistically significant finding i.e. (p < .05).
vBMD = volumetric bone mineral density; CSA = cross sectional area; BMC = bone mineral content.
1 p < .05.
2 p < .01.
3 p < .001 single-sided t test versus 0.
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who had ever taken contraceptives and/or ever smoked, given as
count and percentage of the group (n [%]). Differences between
pregnant and NPNL women at baseline were tested for using
Student’s t tests or Mann–Whitney U tests as appropriate. Unad-
justed change between baseline and second visit for each vari-
able of interest was calculated in absolute units and is reported
as % change ( SD) and one-sided t tests were used to explore
whether within-group change was statistically significant.
Change in bone variables was characterized by estimating lin-
ear regression models for outcome measures at follow-up on
each outcome measure at baseline; standardized residuals from
these models function as Twisk’s recommended measure of
Fig. 1. Regression coefficient and standard error of the mean for HR-pQCT ([A] tibia; [B] radius) and pQCT ([C] tibia; [D] radius) parameters. All parameters
expressed as standardized deviation scores (SDS  SEM).
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“residual change”when data from only two time points are avail-
able and yield a measure of change that is independent of base-
line level.(47) Using this conditional change approach also has the
advantage of minimizing any effects in statistical models of the
high correlation between baseline and follow-up measures.
Multiple linear regression models were used to assess group
differences in change between baseline and follow-up using
these standardized residuals. Covariates included in the initial
models were group, baseline height, baseline weight, age,
parity (0/≥1), smoking history (yes/no), and previous use of con-
traceptives (yes/no). The MASS package in R was used to select a
model of best fit for each bone outcome measure. Initially back-
wards regression was performed (ie, the least significant covari-
ate being removed first and then sequentially) and all models
were then compared and the model with lowest Akaike informa-
tion criterion (AIC) was selected in each case;(48) in these models
of best fit, confounders remained in the model irrespective of
significance. The reason for selecting this analysis approach
was because of multiple collinearity of the covariates when all
were simultaneously included. Group was always included
regardless of significance. In the models, the group coefficients
are reported as the difference in SDS  SEM, representing the
between-group difference in the within-group change between
baseline and follow-up.
Results
Eighty-seven percent of pregnant (n = 46/53) participants and all
NPNL (n = 37) participants were scanned at follow-up. Mean
(SD) estimated gestational age at baseline was 15.5 (0.9) weeks
from the dating scan. Time to follow-up for pregnant women
Table 4. Multiple Regression Models of Change in pQCT and HR-pQCT Bone Outcome Measures at the Distal and Proximal Tibia (Data





score  SEM) Covariates in model of best fit
Group β (SD
score  SEM) Covariates in model of best fit
HR-pQCT n = 65 n = 60
Total vBMD −0.49  0.241 group1, age1, contraceptives 0.05  0.26 group, age1
Trabecular vBMD 0.04  0.25 group, age 0.13  0.26 group
Trabecular
number
0.47  0.231 group1, weight1, parity1 −0.10  0.24 group, weight1, parity1
Trabecular
thickness
−0.47  0.24 group, weight, parity 0.15  0.26 group, weight, parity
Trabecular
separation
−0.54  0.241 group1, weight, parity 0.04  0.25 group, weight1, parity1
Cortical vBMD −0.67  0.232 group2, weight1 −0.16  0.25 group, weight1, parity
Cortical thickness −1.01  0.213 group3, age −0.24  0.25 group, age1
Cortical perimeter 0.78  0.233 group3, parity −0.60  0.22 group
pQCT 4% n = 77 n = 71
Total vBMD −0.65  0.222 group2 −0.18  0.24 group, height, parity,
contraceptives (ever)
Trabecular vBMD −0.50  0.231 group1, weight, parity, ever
smoked
−0.17  0.25 group, weight, parity, smoked
(ever)
Total CSA −0.36  0.23 group 0.07  0.24 group
pQCT 33/38% n = 77 n = 76
Cortical vBMD −0.14  0.23 group, age, height,
contraceptives (ever)
0.50  0.231 group1, parity, smoked (ever)
Cortical BMC −0.13  0.23 group, weight, height1 0.14  0.23 group, parity1
Cortical CSA −0.01  0.23 group, weight, height1 −0.17  0.23 group, weight, smoked (ever),
parity2
Cortical thickness 0.003  0.23 group, height1, contraceptives
(ever)
−0.50  0.221 group1, age1
Total CSA −0.06  0.23 group, smoked (ever) 0.34  0.23 group, parity1
Periosteal
circumference
−0.06  0.23 group 0.40  0.23 group, age
Endosteal
circumference
−0.12  0.23 group 0.46  0.231 group1, age1
Models were run with group, baseline height, weight, age, parity, smoking (ever), and contraceptives (ever) with the model of best fit selected by com-
paring the model AIC values. Bold indicates a statistically significant finding i.e. (p < .05).
β = beta coefficient; ΔSDS = standard deviation score; vBMD = volumetric bone mineral density; BMC = bone mineral content; CSA = cross-sectional
area.
1 p < .05.
2 p < .01.
3 p < .001.
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was 20.1 (2.0) weeks (visit 2 mean gestational age 35.8 [2.1]
weeks), and NPNL time to follow-up did not differ significantly
(21.6 [1.7] weeks). The only significant between-group baseline
difference in participant characteristics (Table 1) was parity, as
controls had a greater median parity (p = .02). Tables 2 and 3 pre-
sent bone data from both visits and percentage change from
baseline for the tibia and radius, respectively. At baseline, signif-
icant between-group differences in bone outcome measures
were only found for tibial trabecular number, which was 9%
lower in pregnant women compared with NPNL (1.98 [0.27] ver-
sus 2.13 [0.27] mm−1, p < .05, Table 2), and trabecular thickness,
which was 11% higher compared with NPNL (0.07 [0.01] versus
0.07 [0.01] mm, p < .05, Table 2). Within-group changes are pre-
sented in Tables 2 and 3; in general, the magnitude of change for
bone outcomes in the pregnant group exceeded those of the
NPNL group.
Changes at the tibia
In pregnant women, total and cortical vBMD (HR-pQCT) at the
distal tibia decreased relative to the NPNL group by 0.49 (0.24)
SDS and 0.67 (0.23) SDS, respectively (p = .04 and p < .01)
(Fig. 1, Table 4). Trabecular bone microarchitecture differed sig-
nificantly between groups: Trabecular number increased by
0.48 (0.23) SDS in pregnant woman compared with NPNL,
whereas trabecular separation 0.54 (0.24) SDS decreased in preg-
nancy (p = .02, p < .01, respectively). Trabecular thickness also
decreased in pregnant women relative to controls, though this
was not statistically significant (p = .06). HR-pQCT cortical thick-
ness decreased by −1.01 (0.21) SDS, whereas cortical perimeter
increased by 0.78 (0.23) SDS (both p < .001). For pQCT at the dis-
tal tibia, significant decreases in total and trabecular vBMD of
0.65 (0.22) SDS and 0.50 (0.23) SDS, respectively, were found for
pregnant compared with controls (p < .01 and p < .05, respec-
tively). In contrast, no significant between-group differences
were found at the cortical-rich 38% proximal tibia site.
Changes at the radius
At the distal radius, no significant difference in any HR-pQCT or
pQCT bone outcome was found between pregnant women
and controls. At the 33% proximal radius, cortical vBMD and
endosteal circumference increased in the pregnant group by
0.50 (0.22) SDS and 0.46 (0.23) SDS, respectively, compared with
controls (both p < .05, Table 4). Cortical thickness decreased by
0.50 (0.23) SDS in pregnant women compared with
NPNL (p < .05).
Discussion
This study presents novel evidence of compartment-specific
changes in maternal bone mineral density, microarchitecture,
geometry, and distribution during pregnancy in women aged
30 to 45 years old. These exceeded the natural age-related
changes that were observed in our control group, although in
keeping with previous studies using pQCT techniques in the
appendicular skeleton, our control group did have small
decreases in several vBMD and related outcomes suggesting a
midlife decline from peak bone mass.(40) Given that the bone-
related changes found in pregnant women occur over and
above this natural age-related decline, the long-term impact of
pregnancy-related mineral mobilization in women in this age
range may be modulated by their ability to restore mobilized
mineral post-lactation and before the onset of menopause.
The magnitude of pregnancy-related changes were relatively
modest across our follow-up period of approximately 20 weeks
but were broadly consistent between two distinct scanning tech-
nologies. The decision not to scan beyond 36 weeks’ gestation
was a pragmatic one, and it is entirely conceivable that total min-
eral mobilization across the entirety of pregnancy would exceed
those presented here.
It is well established that fetal calcium accrual is greatest in
late gestation, and DXA studies with scans from preconception
to within 2 weeks postpartum have previously posited that preg-
nancy could lead to the mobilization of approximately 2% of
maternal skeletal calcium. Our data would seem to support this,
and although we only have peripheral measurements, it is likely
(given what we know of lactation-induced mobilization) that
axial mobilization would be greater. What our data do suggest
is that the maternal skeleton is likely to be an important source
of calcium for the developing fetus.
Tibia
Pregnancy-related change was most evident at the distal tibia
where total vBMD (HR-pQCT and pQCT) decreased relative to
controls. However, total vBMD includes both trabecular and cor-
tical compartments and more nuance can be obtained from
interpreting compartment vBMD. Compartment-specific
changes in vBMD were found with HR-pQCT (cortical vBMD)
and pQCT (trabecular vBMD). Decreases in HR-pQCT cortical
vBMD at the distal tibia were accompanied by decreases in cor-
tical thickness but also an increase in cortical perimeter, perhaps
as a compensatory adaptation. Despite no HR-pQCT trabecular
vBMD group effect, changes in tibia trabecular microarchitecture
were observed with trabecular number increased and trabecular
separation decreased relative to controls. Although trabecular
thickness also decreased in pregnant women versus NPNL, it
was not statistically significant (p = .06). In absolute terms,
within-group decreases in HR-pQCT trabecular vBMD were of
similar magnitude in both groups, while decreases in pQCT tra-
becular vBMD were much greater in pregnant women. As such,
it may be that this discrepancy between pregnancy-related
change in pQCT and HR-pQCT trabecular vBMD outcomes is
the result of the slightly different relative compositions of the
two scan sites imaged because the larger HR-pQCT volume will
have contained a greater proportion of trabecular bone than
the pQCT scan slice. Also, the pQCT trabecular region focuses
on the inner 45% of bone, which may be preferentially mobilized
to limit the effects of bone loss on the mechanical integrity of
bone.(21)
Pregnancy-related changes in trabecular microarchitecture
without trabecular vBMD (HR-pQCT) changes require interpreta-
tion in the context of changes observed in the cortical compart-
ment (ie, decreased cortical vBMD and thickness). First, it is
possible that trabecular microarchitecture changes could be
indicating cortical bone mobilization at the trabecular-cortical
interface; pregnancy-related endosteal resorption leading to cor-
tical thinning coupled with increasing cortical porosity could
“trabecularize” the endocortical surface. This could possibly lead
to pores close to the inter-compartment junction being detected
as part of the trabecular compartment, thereby increasing the
mean trabecular number but decreasing the mean trabecular
thickness. To further investigate that this lack of significant
change in the trabecular compartment was not due to
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intracompartment reorganization, Dinn (trabecular vBMD of the
inner 60% of the trabecular area), Dmeta (remaining 40%), and
ratio of Dinn/Dmeta were also subsequently modeled but
showed no pregnancy-related change. Second, the finding of
microarchitectural changes in the trabecular compartment may
relate to the fact the HR-pQCT voxel size is 82 μm, and although
the largest trabeculae are ~100 μm, many may be considerably
smaller. It may be possible that at baseline, trabeculae that were
very close together were measured as one large trabecula, and
that, as mineral was resorbed, these trabeculae were detected
at follow-up, leading to an increase in measured trabecular num-
ber. This would result in a lower mean trabecular separation and
trabecular thickness.
Radius
There was no evidence of pregnancy-induced mineral mobiliza-
tion at the distal radius, which may suggest that in this popula-
tion, bone mineral is conserved during pregnancy at this site.
The majority of single photon absorptiometry, dual photon
absorptiometry, and DXA studies during pregnancy have found
no pregnancy-related changes in distal radius aBMD, and while
one previous pQCT study reported changes in radius pQCT trabec-
ular vBMD,(37) a more recent pQCT study has not.(38) In contrast,
pregnancy-related changes in vBMD, geometry, and distribution
were found at the cortical-rich proximal radius. From the models,
a significant increase in cortical vBMD was observed, although
given the changes reported in cortical thickness and endosteal cir-
cumference, this could be an artifact of bonemineral mobilization:
As mineral was resorbed from the endocortical surface, the mean
density of voxels nearest the medullary cavity would decrease
below the 710 mg/cm3 threshold at which cortical bone is mea-
sured artificially, increasing the remaining voxels of the cortex.
Decreasing cortical thickness and increasing endosteal circumfer-
ence suggest mobilization from the endocortical surface support-
ing the hypothesis of Garn and others that bone mineral accrued
during growth at the endocortical surface may act as a reservoir
for use during reproduction.(49)
Between-site differences in change
The pattern of pregnancy-related change between the distal
tibia and radius is intriguing. Themajor difference between these
two sites is that the distal tibia is a load-bearing site in contrast to
the distal radius. Previous studies using DXA conducted by our
group have observed the conservation of bone mineral at the
forearm during lactation while mineral was lost from the
weight-bearing hip and lumbar spine.(7,50) Most studies in the lit-
erature where the distal forearm has been scanned with DXA
show no significant bone loss during reproduction. Animal data
suggest that the skeletal system responds to increased calcium
requirements during pregnancy and lactation by selectively
degrading bone from trabecular-rich sites where the bone may
have a more metabolic rather than mechanical function.(21) As
such, the loss would have least impact on the mechanical com-
petence of bone. The sites where this occurs are the more
load-bearing regions, where cortical bone is greatest and may
adapt, postpartum, to maintain skeletal integrity.(21) At present,
human data are few, though the differing pattern of change
reported in the current study indicates some preferential bone
loss at the tibia compared with the radius. However, it is possible
that the impact of decreases in both total and cortical vBMD on
bone strength at the tibia may be somewhat attenuated by the
small but significant increases in cortical perimeter.
Baseline differences in trabecular microarchitecture
A surprising finding was baseline between-group differences in
trabecular number and thickness, which may be indirect evi-
dence of early pregnancy microarchitectural changes, although
without pre-pregnancy data this is speculative. There is a paucity
of literature relating to early pregnancy microarchitectural adap-
tations, although one historical cross-sectional study that
acquired iliac crest biopsies during early pregnancy, late preg-
nancy, and non-pregnant women suggested early pregnancy
trabecular microarchitecture changes might occur.(32,33) How-
ever, caution is required in comparing the current study to the
histological one as the groups in that study differed significantly
in age.
Strengths and limitations
The major strength of this study is that two different pQCT
modalities were used to describe bone density and microarchi-
tecture changes during pregnancy and have been able to con-
trast those changes at weight-bearing and non-weight-bearing
sites. The vast majority of scans were obtained, graded, and ana-
lyzed by a single operator, which reduced any interoperator
effects. In addition, this is the first application of HR-pQCT imag-
ing techniques in pregnancy and one of only a handful of studies
to use conventional pQCT techniques in pregnancy. The use of
HR-pQCT allowed quantification of changes in bone microarchi-
tecture, while pQCT allowed the scanning of cortical-rich sites.
This reduces the likelihood of any of the key findings being
due to chance because both imaging techniques found broadly
similar patterns of change at the distal radius and tibia despite
their different scan sites and methodologies.
The limitations of this study mostly relate to the difficulties of
obtaining in vivo bone densitometry data from pregnant
women; we could only image the peripheral skeleton, scanning
was restricted to a relatively narrow time window for assessing
change, and there were no pre-pregnancy scans. Another limita-
tion is that we cannot determine whether any of the pregnancy-
related changes we documented are recovered postpartum or
during lactation. Changes in the NPNL group for trabecular
vBMD were larger than expected in this age group of women.
However, there is consistency between the pQCT and HR-pQCT
measures in this study and also with DXA data, ranging from
−0.46% to −1% for the hip and spine in a previous study, over
a similar follow-up time, by our group in Cambridge.(7) Addition-
ally the QA scans for both scanners remained within manufac-
turer limits. Finally, we cannot be certain that this is not a
residual effect of post-lactation-associated bone loss as sug-
gested by the recent Bjørnerem study.(51) However, we selected
3 months past end of breastfeeding as an exclusion criteria
based on our previous work(7,50) and it is important to note there
is no consensus regarding the timeline of postpartum changes in
mineralization.(52) In addition, it is likely that the magnitude of
the pregnancy-related changes would have been greater if
follow-up scans had been obtained later in the third trimester.
Furthermore, the relevance of these data to maternal bone
healthmay depend on the extent to which subsequent mobiliza-
tion of bone mineral occurs during lactation if these women
breastfeed, the length and exclusivity of breastfeeding, and
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whether women in this age range have sufficient time to fully
replete their mineral reserves before the onset of menopause.
Conclusion
This study documents for the first time within-pregnancy
changes in both vBMD and bone microarchitecture, with
changes suggestive of mineral resorption found at both the
load-bearing distal tibia in both compartments and at the non-
load-bearing proximal radius where evidence of endosteal
resorption was observed. These changes appear to take place
against a backdrop of natural age-related change in NPNL
women and highlight the need for further research to determine
the impact of reproduction on the maternal skeleton in the
decade(s) preceding menopause. Although the magnitude of
these pregnancy-related changes in the appendicular skeleton
are small, if they reflect global changes across the skeleton at
large they may contribute substantially to the Ca requirements
of the fetus.
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